Marketing-authorisation holder · Italy
Piramal Critical Care Italia S.P.A.
6 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · Italy
6 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ALFENTANIL PIRAMALSoluzione iniettabile | Alfentanil, N.d. | Italy | Authorised | |
| DIMETILFUMARATO PIRAMALCapsula rigida gastroresistente | Dimethyl | Italy | Authorised | |
| FENTANESTSoluzione iniettabile | Fentanyl | Italy | Authorised | |
| ICATIBANT PIRAMALSoluzione iniettabile in siringa pre-riempita | Icatibant | Italy | Authorised | |
| SUFENTANIL PIRAMALSoluzione iniettabile | Sufentanil | Italy | Authorised | |
| TIGECICLINA PIRAMALPolvere per soluzione per infusione endovenosa | Tigecycline | Italy | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 6 | 6 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.